Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

VIM: New Route, Same Destination

Posted on by CDC's Safe Healthcare Blog
Alexander J. Kallen, MD, MPH
Alexander J. Kallen, MD, MPH

Author – Alexander Kallen, MD, MPH
Medical Officer
CDC’s Division of Healthcare Quality Promotion

Last week my colleague Dr. Brandi Limbago addressed the issue of carbapenem-resistant Enterobacteriaceae (CRE) and specifically enzymes called KPCs and NDM-1s that are causing the bacteria to become resistant to last-resort antibiotics. Today, CDC released a report about another enzyme causing CRE. This one is called VIM (Verona integron-encoded metallo-beta-lactamase). VIM has been found previously in a number of countries including Greece where this patient had been transferred from. View recommendations for surveillance and prevention here.

Just as Dr. Limbago mentioned last week, these enzymes are new routes to the same destination: CRE. All types of CRE are significant and emerging public health problems, regardless of their route to resistance or their country of origin. The fact is that we live in a very small world, medically speaking, and it’s not surprising that these organisms are moving from country to country. This situation simply reinforces the need for better antibiotic stewardship, transmission prevention and overall healthcare-associated infection (HAI) prevention in every hospital and practice – today.

Posted on by CDC's Safe Healthcare Blog

4 comments on “VIM: New Route, Same Destination”

Comments listed below are posted by individuals not associated with CDC, unless otherwise stated. These comments do not represent the official views of CDC, and CDC does not guarantee that any information posted by individuals on this site is correct, and disclaims any liability for any loss or damage resulting from reliance on any such information. Read more about our comment policy ».

    Yes there should realize the opportunity to RSS commentary, quite simply, CMS is another on the blog.

    This is a very good report. It is clear that over use of antibiotics is leading to antibiotic resistant HAIs. But we still need development and testing of new antibiotics as part of the anti-HAI treatment process. We need new medications that will attack and kill the enzymes that seem to allow HAIs to thrive. We to improve communications to the health care community on the importance of doing basic steps to control HAIs like the washing of hands, the proper disposal of medical waste, proper steralization, proper set up and use of IV and catheter lines, daily patient baths with anti-microbial soap will all play a big role in reducing and eliminating HAIs. And HAI control should not only apply to hospitals. It needs to cover medical offices, kidney dialisys storefront locations in strip malls, and one place that has not been mentioned yet but needs to be looked into as a place for possible HAI infections as well–dental offices. Best wishes, Michael E. Bailey.

Post a Comment

Your email address will not be published.

All comments posted become a part of the public domain, and users are responsible for their comments. This is a moderated site and your comments will be reviewed before they are posted. Read more about our comment policy »